Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
Vaughn CP, Costa JL, Feilotter HE, Petraroli R, Bagai V, Rachiglio AM, Marino FZ, Tops B, Kurth HM, Sakai K, Mafficini A, Bastien RRL, Reiman A, Le Corre D, Boag A, Crocker S, Bihl M, Hirschmann A, Scarpa A, Machado JC, Blons H, Sheils O, Bramlett K, Ligtenberg MJL, Cree IA, Normanno N, Nishio K, Laurent-Puig P. Vaughn CP, et al. Among authors: hirschmann a. BMC Cancer. 2018 Aug 16;18(1):828. doi: 10.1186/s12885-018-4736-4. BMC Cancer. 2018. PMID: 30115026 Free PMC article.
KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.
Dijkstra JR, Heideman DA, Meijer GA, Boers JE, 't Hart NA, Diebold J, Hirschmann A, Hoefler G, Winter G, Miltenberger-Miltenyi G, Pereira SV, Richman SD, Quirke P, Rouleau EL, Guinebretiere JM, Tejpar S, Biesmans B, van Krieken JH. Dijkstra JR, et al. Among authors: hirschmann a. Virchows Arch. 2013 Jan;462(1):39-46. doi: 10.1007/s00428-012-1356-2. Epub 2012 Dec 15. Virchows Arch. 2013. PMID: 23242173
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
Gautschi O, Pauli C, Strobel K, Hirschmann A, Printzen G, Aebi S, Diebold J. Gautschi O, et al. Among authors: hirschmann a. J Thorac Oncol. 2012 Oct;7(10):e23-4. doi: 10.1097/JTO.0b013e3182629903. J Thorac Oncol. 2012. PMID: 22743296 Free article. No abstract available.
Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.
Gautschi O, Peters S, Zoete V, Aebersold-Keller F, Strobel K, Schwizer B, Hirschmann A, Michielin O, Diebold J. Gautschi O, et al. Among authors: hirschmann a. Lung Cancer. 2013 Nov;82(2):365-7. doi: 10.1016/j.lungcan.2013.08.012. Epub 2013 Aug 19. Lung Cancer. 2013. PMID: 24035431
A patient with lung adenocarcinoma and RET fusion treated with vandetanib.
Gautschi O, Zander T, Keller FA, Strobel K, Hirschmann A, Aebi S, Diebold J. Gautschi O, et al. Among authors: hirschmann a. J Thorac Oncol. 2013 May;8(5):e43-4. doi: 10.1097/JTO.0b013e31828a4d07. J Thorac Oncol. 2013. PMID: 23584301 Free article. No abstract available.
Microsatellite instability and loss of heterozygosity in prostatic carcinomas: comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases.
Rohrbach H, Haas CJ, Baretton GB, Hirschmann A, Diebold J, Behrendt RP, Löhrs U. Rohrbach H, et al. Among authors: hirschmann a. Prostate. 1999 Jun 15;40(1):20-7. doi: 10.1002/(sici)1097-0045(19990615)40:1<20::aid-pros3>3.0.co;2-4. Prostate. 1999. PMID: 10344720
89 results